PRESS RELEASE

Hermia at EANM 2024

Witness the exciting Hermia news at the Hermes Medical Solutions booth at EANM 2024

Hermes Medical Solutions (HMS), global market leader in molecular imaging and dosimetry software solutions is excited to showcase all new and upcoming product updates to the All-in-One Molecular Imaging Software Suite Hermia at EANM 2024.

HMS will present its latest software enhancements at the upcoming European Association of Nuclear Medicine (EANM) 2024 conference. These updates are designed to support nuclear medicine professionals by improving the efficiency and accuracy of image processing workflows.
“We look forward to sharing our latest updates with the medical community at EANM 2024.” Tom Francke, CEO of Hermes Medical Solutions.


The product updates include:

Hermia SIRT

For Selective Internal Radiation Therapy. SIRT is currently used in the treatment of liver tumors either from primary liver cancer or metastatic (e.g. colorectal primary cancer). Care must be taken to administer the necessary amount of activity to deliver a therapeutic radiation dose to the tumor while maintaining a low dose to normal tissue.

Key features

•    Automatic CT-based liver and lung segmentation
•    Live feedback of optimised dose results for personalized treatment
•    Plan multiple activity injections for optimal dosage
•    Single-click SPECT-based segmentation to plan multiple target lesions
•    Implements EANM recommendations for SIRT dosimetry, including “2 volume” method for region activity and volume Automated 3D lung shunt calculation
•    Deformable registration of planning regions to verification image for accurate post-therapy assessment
•    Support for 90Y resin and glass microspheres and 166Ho microspheres DICOM report of dose planning and verification and saved regions 

Hermia Neurology

Hermia Neurology is the state of the art software for neurology examinations, including degenerate diseases.

Key features

•    Centiloid scale is included in the novel neurology

Hermia Lung Lobar Quantification

Hermia Lung Lobar Quantification improves outcomes for patients undergoing lung volume reduction surgery with accurate Lung Lobe Quantification method. Hermia includes a new modern solution for Lung Lobar Quantification and automated workflows.

Hermia Voxel Dosimetry

In Hermia Voxel Dosimetry, Hänscheid method, effective half-life, and physical half-life assumptions are available to facilitate dosimetry from a single image time point improving patient experience and simplifying departmental logistics.

Time saving features

•    Automatic organ segmentation 
•    Improved ability to fill in information automatically from header
•    Reduced calculation times
•    Automated workflow configuration options

Enhancements

•    Enhanced alignment of voxel-to-voxel registration with new deformable registration to accommodate patient movement and breathing corrections
•    Reduced sensitivity to noise
•    New alpha emitting isotopes
•    Improved compatibility with Spectrum Dynamics Quantitative SPECT

Book your demo at EANM

Visit Hermes Medical Solutions’ booth in Foyer 3 at this year’s EANM and see for yourself all the new and upcoming software updates.

 

About Hermes Medical Solutions

Hermes Medical Solutions continuously innovates to enable faster and more personalized diagnosis and therapies in molecular imaging. With Hermia, we empower healthcare professionals with state-of-the-art software for all clinical scenarios into ONE vendor-neutral platform. Powerful tools enable clinicians to simplify their workflow and keep pace with the fast development of scanners, tracers and procedures in nuclear medicine. The result is improved quality in patient management and decision support for thousands of healthcare providers and their patients worldwide.
www.hermesmedical.com

 

Contact

Tom Francke
CEO, Assoc. Prof.

Hermes Medical Solutions AB (HQ)
Strandbergsgatan 16
112 51 Stockholm, Sweden
Tel: +46 70 166 1234
tom.francke@hermesmedical.com